CedProf: The Neolpharma Group has a Research and Development Center for Differentiated Products where various pharmaceutical forms are developed for its products; this, in order to improve adherence to treatment.
Cidat: The Pharmacovigilance, Research and Early Detection Center, with which we keep constant contact in case any questions arise or adverse reactions in patients are detected. This Center performs the following activities:
Diagnostic imaging (electroencephalogram (EEG) and EKG).
Monitoring of clinical studies, Stage I, II, III and IV.
CIM: Drug Information Centre (CIM), with a comprehensive database containing updated surveys on each drug, allowing specialists to have information on pharmacokinetics, pharmacodynamics and therapeutic indications, among others.
This effort is made possible by the investment of 10% of Neolpharma Group's total sales for research and development, which also enables us to endorse publishing projects that address various health issues.